Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 4Breast Neoplasms 3Prostatic Neoplasms 2Melanoma 2Healthy Participants 2Carcinoma, Non-Small-Cell Lung 2Advanced Solid Tumor 2cMET-dysregulated Advanced Solid Tumors 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Solid Tumor 1Neoplastic Cells, Circulating 1Liver Cirrhosis 1

Interventions

Blood Specimen Collection 13Reverse Transcriptase Polymerase Chain Reaction 7Flow Cytometry 7Surgical Procedures, Operative 3Pirinitramide 2Morphine 2Bevacizumab 2ribociclib 1lanreotide 1jinfukang 1eribulin 1cabazitaxel 1Zoledronic Acid 1Vinorelbine 1Trastuzumab 1Thiotepa 1Taxes 1Stem Cell Transplantation 1Standard of Care 1Spinal Puncture 1Sorafenib 1Radiofrequency Ablation 1Propofol 1Pemetrexed 1Octreotide 1Letrozole 1Lapatinib 1Injections, Epidural 1Injections 1Hematologic Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplastic Cells, Circulating × Digoxin × Clear all
NCT03928210 2023-12-13

Digoxin Induced Dissolution of CTC Clusters

University Hospital, Basel, Switzerland

Phase EARLY_PHASE1 Completed
58 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡